Neo Ivy Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.21M Buy
+16,668
New +$1.19M 0.82% 12
2022
Q3
Sell
-3,969
Closed -$249K 481
2022
Q2
$249K Buy
3,969
+583
+17% +$38.6K 0.67% 30
2022
Q1
$238K Buy
+3,386
New +$229K 0.21% 171
2021
Q4
Sell
-8,098
Closed -$296K 557
2021
Q3
$296K Buy
8,098
+61
+0.8% +$3.67K 0.34% 108
2021
Q2
$481K Buy
+8,037
New +$509K 0.49% 63
2021
Q1
Sell
-18,695
Closed -$878K 573
2020
Q4
$878K Buy
18,695
+18,482
+8,677% +$801K 0.98% 7
2020
Q3
$7K Sell
213
-7,885
-97% -$299K 0.01% 434
2020
Q2
$296K Buy
8,098
+7,858
+3,274% +$274K 0.34% 108
2020
Q1
$7K Buy
+240
New +$10.6K 0.01% 425
2019
Q1
Sell
-13,722
Closed -$563K 361
2018
Q4
$563K Buy
+13,722
New +$589K 0.44% 93

Other funds holding MET

Neo Ivy Capital Management's MET Position: Q4 2022 in Review

Neo Ivy Capital Management opened a new position in MetLife (MET) in Q4 2022: 16,668 shares worth $1.21M. The stake represents 0.82% of the portfolio and ranks #12 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in MET as recently as Q2 2022.

Neo Ivy Capital Management first reported a position in MET in Q4 2018 and has held it in 10 quarters since. 1,316 funds tracked by Wall St. Rank hold MET as of Q4 2022.

  • Neo Ivy Capital Management held 16,668 shares of MetLife worth $1.21M as of Q4 2022.
  • MetLife was a new Neo Ivy Capital Management position in Q4 2022.
  • MetLife made up 0.82% of Neo Ivy Capital Management's portfolio in Q4 2022, its #12 holding.
  • Neo Ivy Capital Management first reported a position in MetLife in Q4 2018 and has held it in 10 quarters since.
  • 1,316 funds tracked by Wall St. Rank held MetLife as of Q4 2022.

Based on Neo Ivy Capital Management's 13F filing for Q4 2022, filed 27 Mar 2023.